Skip to main content
. Author manuscript; available in PMC: 2011 May 31.
Published in final edited form as: Acta Neuropathol. 2009 Aug 2;119(1):111–122. doi: 10.1007/s00401-009-0576-2

Table 1.

Progranulin (GRN) genetic variants included in this study

Cases cDNA Protein Diagnosis Tissue References
1, 2 c.1252C>T R418X FTLD-TDP (autopsy) Brain [5]
3 c.1477C>T R493X FTLD-TDP (autopsy) Brain [22]
4 c.348A>C A89VfsX139 FTLD-TDP (autopsy) Brain a
5 c.911G>A W304X FTLD-TDP (autopsy) Brain [22]
6b c.1009C>T Q337X FTLD-TDP (autopsy) Brain [48]
c.903G>A S301S
c.1070C>A P357R
7 c.1179 + 2T>C V395YfsX29 FTLD-TDP (autopsy) Brain a
8 c.26C>A A9D FTLD-TDP (autopsy) Brain [22]
9 c.1414-2A>G A472VfsX10 FTD/PPA (clinical) Blood a
10 c.1317_1318delCA D441HfsX4 FTLD-TDP (autopsy) Blood a
11 c.154delA T52HfsX2 FTLD-TDP (autopsy) Blood [22]

All variants are believed to be pathogenic. For cases 1–8, brain tissue was analyzed. For cases 9–11, peripheral blood mRNA was used. For cases 10 and 11, autopsy information subsequently became available and is shown in the table. Case 8, with the GRN variant c.26C>A, was included in protein studies only, as others have shown that this mutation may not show mRNA transcript haploinsufficiency [35]

FTLD-TDP frontotemporal lobar degeneration with TDP-43 inclusions, FTD frontotemporal dementia, PPA primary progressive aphasia

a

Yu et al. (in press) Arch Neurol

b

Case has three progranulin variations